Monday , November 20 2017
Home / Resources / Videos / Dr. Carol Wysham, Q1 Expectations of the 2012 ADA meeting

Dr. Carol Wysham, Q1 Expectations of the 2012 ADA meeting

Dr. Wysham tells us about her anticipation of the results of two specific trials, one a study on an old-fashioned remedy called salsalate, and then the ORIGIN trial results which looked at the effects on cardiovascular disease with early intervention with insulin. 

More videos with Dr. Wysham:

Dr. Carol Wysham, Introduction

Q2 SGLT2 Differences

Q3 Tips for Lowering A1c

Q4 Issues with Patients on Nutrition and Fitness Medicine

Q5: What Would You Like Your A1c to Be?

Dr. Carol Wysham is Adjunct Research Professor within the Department of Pharmacotherapy at Washington State University, Assistant Clinical Professor of Medicine at the University of Washington School of Medicine and is Section Head of the Department of Endocrinology at Rockwood Clinic in Spokane, Washington. Her current areas of research interest include reduction of CVD risk in type 2 diabetes and improving delivery of care for diabetes. She has been involved with numerous trials for the National Institute of Health including the ACCORD Trial and the AIM-High Trial.